We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

47 hedge funds and large institutions have $94.5M invested in VanEck Pharmaceutical ETF in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $57.7M → $94.5M (+$36.7M)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

7.82% more ownership

Funds ownership: 32.75% → 40.57% (+7.8%)

7% more funds holding

Funds holding: 44 → 47 (+3)

17% less call options, than puts

Call options by funds: $1.34M | Put options by funds: $1.62M

29% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 14

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
14
Closed
5
Calls
$1.34M
Puts
$1.62M
Net Calls
-$274K
Net Calls Change
-$970K

Top Buyers

Rank Fund Capital Flow
1
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
+$41.6M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.26M
3
TRCT
Tower Research Capital (TRC)
New York
+$804K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$672K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$554K

Top Sellers

Rank Fund Capital Flow
1
OPS
Orion Portfolio Solutions
Nebraska
-$5.74M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$5.46M
3
Bank of America
Bank of America
North Carolina
-$5.14M
4
BCI
Brinker Capital Investments
Pennsylvania
-$423K
5
DI
DFPG Investments
Utah
-$287K
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
26
Advisornet Financial
Minnesota
$50K +$48.4K +800 New
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$37.4K – – –
LWM
28
Liberty Wealth Management
California
$37K +$242 +4 +0.7%
CG
29
Cutler Group
California
$31K -$60.5K -1,000 -67%
CFGS
30
Concourse Financial Group Securities
Alabama
$31K – – –
Citigroup
31
Citigroup
New York
$27K +$6.05K +100 +30%
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$22K – – –
MIM
33
Macroview Investment Management
Maryland
$19K – – –
EIP
34
Ellis Investment Partners
Pennsylvania
$16K +$121 +2 +0.8%
LS
35
Leelyn Smith
Illinois
$15K – – –
PAG
36
Private Advisor Group
New Jersey
$15K +$14.7K +243 New
IA
37
IFP Advisors
Florida
$13K -$23.7K -392 -61%
Fidelity Investments
38
Fidelity Investments
Massachusetts
$12K -$60 -1 -0.5%
JCM
39
Jacobi Capital Management
Pennsylvania
$12K – – –
CAN
40
Cetera Advisor Networks
California
$12K +$12.1K +200 New
HCM
41
Highlander Capital Management
New Jersey
$9K – – –
ADL
42
Asset Dedication LLC
California
$9K +$8.89K +147 New
Barclays
43
Barclays
United Kingdom
$6K – – –
SFS
44
Sowell Financial Services
Arkansas
$6K – – –
FANJ
45
Financial Architects (New Jersey)
New Jersey
$5K +$60 +1 +1%
AIM
46
Anchor Investment Management
South Carolina
$3.61K – – –
WCG
47
Weaver Consulting Group
California
$1K – – –
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
– -$5.46M -100,406 Closed
MIH
49
Meitav Investment House
Israel
– -$266K -4,895 Closed
ASN
50
Advisory Services Network
Georgia
– -$18K -340 Closed
1
2
3

PPH Hedge Fund Activity: Q2 2020 in Review

47 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q2 2020, worth a combined $94.5M — up 64% from $57.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PPH positions and 5 closed out — a net gain of 3 holders — while 10 added to existing stakes and 14 trimmed.

The largest buyer was Mivtachim The Workers Social Insurance Fund, opening a new position worth an estimated $41.6M. The largest seller was Orion Portfolio Solutions, cutting an estimated $5.74M.

  • 47 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q2 2020, up from 44 in Q1 2020.
  • Funds reported $94.5M of VanEck Pharmaceutical ETF stock for Q2 2020, up 64% quarter-over-quarter.
  • 8 funds opened new VanEck Pharmaceutical ETF positions in Q2 2020 and 5 closed out, a net change of +3 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q2 2020 was Mivtachim The Workers Social Insurance Fund, an estimated $41.6M added.
  • The largest VanEck Pharmaceutical ETF seller in Q2 2020 was Orion Portfolio Solutions, an estimated $5.74M sold.

Based on aggregated 13F filings for Q2 2020.